Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Lung Cancer Diagnostic And Screening Market Poised To Hit $4.04 Billion By 2030 With A 9.6% CAGR
The lung cancer diagnostic and screening market size has experienced robust growth in recent years. It is projected to expand from $2.56 billion in 2025 to $2.8 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. Historically, this growth has been driven by factors such as the high prevalence of smoking-related lung cancer, the widespread adoption of chest X-ray and CT imaging, the expansion of hospital-based diagnostic infrastructure, increasing awareness surrounding early lung cancer detection, and the rise of biopsy-based diagnostic confirmation.
The lung cancer diagnostic and screening market is projected for significant expansion over the coming years. This market is set to reach $4.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. Factors driving this growth during the forecast period include the broadening of national lung cancer screening programs, the increasing uptake of low-dose CT screening, a rising demand for biomarker and blood-based tests, escalating healthcare investments in oncology diagnostics, and enhanced accessibility to diagnostic imaging centers. Key trends anticipated in the forecast period encompass a greater acceptance of early lung cancer screening initiatives, an expanding utilization of advanced imaging and biomarker tests, a heightened emphasis on screening high-risk populations, the proliferation of non-invasive diagnostic methods, and an increasing integration of multimodal diagnostic pathways.
Get A Free Sample Report With In-Depth Market Insights:
Lung Cancer Diagnostic And Screening Market Development Factors: What’s Supporting Demand?
The growing incidence of lung cancer is projected to drive the expansion of the lung cancer diagnostic and screening market moving forward. Lung cancer is a severe illness marked by the uncontrolled multiplication of abnormal cells in the lung tissues, manifesting symptoms such as coughing, chest pain, and difficulty breathing. Lung cancer diagnosis and screening enable the early detection of the disease in patients through various tests, including an incisional biopsy and a bronchoscopy. For example, in January 2023, the American Cancer Society, a US-based government organization, reported approximately 238,340 new cases of lung cancer in the United States (117,550 in men and 120,790 in women). Furthermore, there were reportedly 127,070 deaths attributed to lung cancer (67,160 in men and 59,910 in women). Hence, the increasing prevalence of lung cancer is a key driver for the growth of the lung cancer diagnostic and screening market.
Lung Cancer Diagnostic And Screening Market Segment Outlook: Which Categories Are Growing Fastest?
The lung cancer diagnostic and screening market covered in this report is segmented –
1) By Product: Instruments, Consumables And Accessories
2) By Test: Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests
3) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer
4) By End User: Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Imaging Devices, Biopsy Devices, Bronchoscopy Systems
2) By Consumables And Accessories: Biopsy Needles, Reagents And Assays, Imaging Contrast Agents, Sample Collection Kits
Lung Cancer Diagnostic And Screening Market Transformation Trends: What Innovations Are Driving Change?
Major companies in the lung cancer diagnostic and screening market are concentrating on developing a blood-based test that utilizes machine learning, such as whole-genome machine learning, to provide accessible and convenient lung cancer screening and gain a competitive edge in the market. Whole-genome machine learning involves the application of machine learning algorithms to analyze and interpret comprehensive sets of genetic information, encompassing an organism’s entire genome. For instance, in October 2023, DELFI Diagnostics Inc., a US-based developer of accessible blood-based tests, launched FirstLook Lung, a blood test using whole-genome machine learning to analyze cell-free DNA fragments, enhancing lung cancer screening with a 99.7% NPV. The test, designed for routine blood work, identifies individuals with potential lung cancer, including early-stage disease. Addressing low LDCT screening uptake, the test aims to improve population health.
Lung Cancer Diagnostic And Screening Market Leading Companies And Competitive Benchmarking
Major companies operating in the lung cancer diagnostic and screening market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, Oncimmune Holdings Plc, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix, OncoCyte, Broncus Medical Inc.
View The Full Lung Cancer Diagnostic And Screening Market Report:
Lung Cancer Diagnostic And Screening Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the lung cancer diagnostic and screening market in 2025. The regions covered in the lung cancer diagnostic and screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
